1. Home
  2. |Insights
  3. |Emerging Issues in Sanctions, AML and Everything in Between

Emerging Issues in Sanctions, AML and Everything in Between

Webinar | 04.28.20, 6:00 AM EDT - 7:00 AM EDT

Register

Managing an AML Program in the Time of COVID-19: Adjusting Operations and Dealing with Paycheck Protection Program Loans Under the CARES Act.


Crowell & Moring LLP’s sanctions and anti-money laundering professionals bring you the second webinar in our series, Emerging Issues in Sanctions, AML, and Everything in Between in the Time of COVID-19. On April 2nd our team hosted the following webinar: “Virtual” Sanctions Compliance: Managing Your Team and Getting Your Regulatory Updates. We now continue the conversation with that event’s AML counterpart.


During this webinar, Carlton Greene (former FinCEN Chief counsel) , Caroline Brown (Former Treasury and U.S. Department of Justice attorney) and Erik Woodhouse (Former U.S. Treasury Official & U.S. State Department attorney), will discuss:


  • AML Operations Best Practices during COVID-19
  • Discussion of Financial Crimes Enforcement Network (FinCEN) Guidance
  • Discussion of Federal Financial Institutions Examination Council (FFIEC) Guidance
  • Internal Considerations (Messaging, Coordination, Automation, Risk Assessments, and Contingency Plans)
  • External Considerations (Customer Circumstances, Regulatory Flexibility, and Communication with Regulators)
  • New Risks and Activity Patterns
  • Quality versus Speed
  • Conducting Customer Diligence During COVID-19
  • Beneficial Ownership & Paycheck Protection Program Loans Under the CARES Act

Dress Code: Still sweatpants.


For more information, please visit these areas: International Trade

Contact

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.

View All Insights